Netherlands vs World: Access to anti-retroviral drugs, male
Netherlands
89.0%
in 2023
World
73.0%
in 2024
Netherlands rank
17th
World rank
15th
Access to anti-retroviral drugs, male over time
- Netherlands
- World
How they compare
Netherlands currently reports 89.0% against 73.0% in World, a difference of 16.0%.
That makes Netherlands's figure about 1.2 times World's.
Across all 24 years both countries report, Netherlands has been ahead every year.
Netherlands ranks 17th and World ranks 15th of 141 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Netherlands | World | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.8% | 7.1% | 43.7% | Netherlands |
| 2010s | 76.8% | 40.6% | 36.2% | Netherlands |
| 2020s | 88.2% | 66.2% | 22.0% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Netherlands or World?
- Netherlands, at 89.0% against 73.0% in World as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Netherlands and World?
- 16.0%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and World?
- 24 years are reported by both, from 2000 to 2023.
- How do Netherlands and World rank globally for access to anti-retroviral drugs, male?
- Netherlands ranks 17th and World ranks 15th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.